Honey framework targets authenticity testing gap

Honey framework targets authenticity testing gap

UK agencies are tightening scrutiny of honey authenticity testing databases. The framework aims to strengthen enforcement confidence as manufacturers, packers, and ingredient buyers face persistent fraud risk.


IN Brief:

  • A Food Authenticity Programme report has examined how proprietary honey authenticity databases can be assessed for fitness for purpose.
  • The framework aims to support more reliable enforcement decisions and reduce legal ambiguity around honey testing.
  • Honey fraud remains difficult to police because no single analytical method can determine authenticity across all cases.

The Food Standards Agency, Defra, Food Standards Scotland, and the Government Chemist have supported new work to improve how honey authenticity databases are assessed.

The framework addresses a long-running weakness in fraud testing and enforcement: proprietary honey authenticity databases can influence major commercial and regulatory decisions while remaining largely unpublished. Those databases may help determine whether a product is judged authentic, whether a supplier is challenged, and whether enforcement action can be pursued.

The work was commissioned through the Food Authenticity Programme and builds on earlier expert discussions involving government, scientists, and industry. Its purpose is to provide a structured way of assessing whether authenticity databases are fit for purpose, particularly where analytical results may be disputed.

Honey is a difficult authenticity category because its composition varies naturally by floral source, geography, climate, harvesting practice, and post-harvest handling. Testing is further complicated by the use of different analytical methods, including nuclear magnetic resonance and other techniques intended to detect exogenous sugars or verify origin. No single test can provide a universal answer in every case.

That complexity creates risk for manufacturers, packers, importers, and retailers. Honey is sold as a consumer product, but it is also used in bakery, cereals, sauces, marinades, confectionery, drinks, and functional formulations. If authenticity controls are uncertain, the exposure moves through the supply chain into product claims, supplier assurance, brand protection, and legal compliance.

European scrutiny of honey fraud has grown since a 2023 investigation found that 46% of sampled honey products were suspected to be fraudulent. UK samples performed poorly in that exercise, increasing pressure for stronger testing, clearer country-of-origin rules, and more reliable enforcement tools.

The framework lands alongside a wider shift toward evidence-led ingredient assurance. IFF’s Madagascar vanilla innovation centre placed crop origin, extraction, flavour creation, and application work closer together, while IMCD’s Türkiye technical centre expanded formulation support across dairy, bakery, beverages, confectionery, meat, and savoury applications. Ingredients are being judged increasingly by traceability, technical performance, and supply confidence, not only price.

Honey fraud control sits at the harder end of that assurance challenge. Unlike a standardised functional ingredient, honey is biologically variable and globally traded. A testing database that performs well for one origin, crop pattern, or product type may be weaker when applied to another. Without transparent criteria for database design, sample quality, reference material, and statistical limits, disputes can become legal rather than scientific.

A more structured approach to database assessment should help enforcement bodies and businesses challenge the tools behind authenticity decisions. Fraud prevention depends on confidence in the test system as much as confidence in the supplier.

For manufacturers using honey as an ingredient, authenticity needs to sit inside specification management rather than procurement alone. Supplier approval, origin documentation, testing strategy, risk assessment, and contract terms all need to align. Cheap honey will remain commercially tempting, but weak assurance is becoming a more expensive risk.


Stories for you


  • EPAX Cetoleic 2040 lowers LDL in clinical trial

    EPAX Cetoleic 2040 lowers LDL in clinical trial

    EPAX Cetoleic 2040 reduced LDL-cholesterol by 7% after eight weeks in a randomised clinical trial of overweight and obese adults, adding human data to the emerging category of marine long-chain monounsaturated fatty acids.


  • T. Hasegawa targets dairy-free flavour gap

    T. Hasegawa targets dairy-free flavour gap

    T. Hasegawa USA has launched HASEMILK, a powdered dairy-free flavour technology designed to recreate milk taste, aroma, and mouthfeel in plant-based beverages, bakery, desserts, sauces, and dry mixes.